KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Hologic (HOLX) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to 25.13%.

  • Hologic's EBITDA Margin rose 3600.0% to 25.13% in Q4 2025 from the same period last year, while for Dec 2025 it was 18.12%, marking a year-over-year decrease of 50900.0%. This contributed to the annual value of 20.08% for FY2025, which is 42900.0% down from last year.
  • Latest data reveals that Hologic reported EBITDA Margin of 25.13% as of Q4 2025, which was up 3600.0% from 22.57% recorded in Q3 2025.
  • Over the past 5 years, Hologic's EBITDA Margin peaked at 51.82% during Q1 2021, and registered a low of 0.7% during Q1 2025.
  • Moreover, its 5-year median value for EBITDA Margin was 24.6% (2022), whereas its average is 24.57%.
  • As far as peak fluctuations go, Hologic's EBITDA Margin surged by 311400bps in 2021, and later plummeted by -261800bps in 2023.
  • Hologic's EBITDA Margin (Quarter) stood at 43.59% in 2021, then plummeted by -44bps to 24.43% in 2022, then dropped by -20bps to 19.56% in 2023, then increased by 27bps to 24.77% in 2024, then rose by 1bps to 25.13% in 2025.
  • Its EBITDA Margin stands at 25.13% for Q4 2025, versus 22.57% for Q3 2025 and 24.87% for Q2 2025.